Seojin Seok, CEO of Celltrion, "Expecting Visible Results This Year"

Seo Jin-seok: "Visible Performance Growth Expected This Year"
Celltrion to Decide on Seo Jung-jin's Reappointment as Inside Director at Shareholders' Meeting

Seo Jin-seok, CEO of Celltrion, is speaking at the regular shareholders' meeting held on the 25th at Songdo Convensia in Yeonsu-gu, Incheon. Photo by Celltrion

Seo Jin-seok, CEO of Celltrion, stated that visible performance growth can be expected this year.

At the regular shareholders' meeting held on the 25th at Songdo Convensia in Yeonsu-gu, Incheon, CEO Seo said, "The recent global economic environment is facing difficulties due to various factors such as unstable conditions, domestic political changes, and U.S. tariff issues. The domestic stock market is also showing a generally sluggish trend." However, he added, "Celltrion has passed the transitional period after last year's merger and has now reached a stage where visible performance growth can be expected in earnest starting this year."

He continued, "We will do our best to increase corporate value based on solid achievements and future growth engines, including expanding the global market share of major products, launching new product sales, and developing new drugs based on accumulated technological capabilities."

At the regular shareholders' meeting held that day, Celltrion will decide on the reappointment of Chairman Seo Jung-jin as an inside director. Previously, in 2021, Chairman Seo voluntarily stepped down from the front lines of management but returned after two years as an inside director and co-chairman of the board, citing the need for leadership. His term expires this month.